At Axcellant, we excel in driving innovation and compliance in the Medical Device and Software as a Medical Device (SaMD) sectors. With a proven track record of success, we offer comprehensive solutions spanning every stage of product development.
Integrated Medical Device and SaMD Compliance Services encompass a holistic approach to advancing medical devices and software-based solutions, ensuring they meet the highest regulatory standards globally. These services focus on aligning product development with compliance frameworks like ISO standards, EU MDR, and FDA CFR while fostering innovation and efficiency. Covering every aspect – from design and development planning to post-market activities – they provide seamless support for achieving product safety, efficacy, and market success.
Our team meticulously plans and implements step-by-step processes, ensuring precision and compliance at every stage of product development. This wealth of experience allows us to manage complex studies with efficiency and reliability, delivering impactful results that align with regulatory requirements and client objectives. From strategy formulation to clinical study management, regulatory submissions, and lifecycle documentation, our expertise is the foundation of every successful project.
Critical planning of clinical and validation studies for medical devices and SaMD is at the heart of this process, as it lays the groundwork for robust data, successful trials, and compliance with stringent regulatory standards. At Axcellant, the execution of various clinical studies is driven by years of expertise gained through our extensive work in the medical device and SaMD sectors.
Axcellant provides end-to-end support for the medical device industry, including:
Reach out today to explore how Axcellant’s tailored services can elevate your medical device project.
The EU is moving forward with key upgrades to its medical device and diagnostics regulations, specifically under the Medical Device…
Gene therapies now account for most ATMP clinical trials, with a balanced distribution between in vivo and ex vivo approaches.…
Academic medical centers in the US are voicing concern over reduced funding from the National Institutes of Health (NIH). While…
Copyright @ 2025 Axcellant